# K170825: SnoreRx

- Pathway: 510(k) (Abbreviated)
- Applicant: Apnea Sciences Corporation
- Decided: Aug 18, 2017 after 151 days
- Product code: LRK (Device, Anti-Snoring)
- Device class: 2
- Regulation: 21 CFR 872.5570
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K071404 (2007). 10 ancestors in all.
21 later devices descend from it; 11 cite it directly.
0 of 32 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K153200: SnoreRx, Apnea Sciences Corporation (2016) Summary page 4.

## Most influential descendants
- K233850: Difiney Anti Snoring Device (2024), 3 descendants of its own
- K191618: SleepTight Mouthpiece STZ (2019), 3 descendants of its own
- K200657: SmartGuard Anti-Snoring Device (2021), 2 descendants of its own
- K253845: Anti Snoring Mouthpiece (L08-BP, L08-PT, L08-BT, L08-TP, L08-TB, L08-PB) (2026), 1 descendant of its own
- K252531: Myosa (S1H, S1, S2, S3, S1M, S2M); Myosa for Snorers (S1, S1M, S2) (2026), 1 descendant of its own

## Indications for use
The SnoreRx is intended for use on adult patients 18 years of age or older as an aid for the reduction of snoring.

Source page: https://510kreport.com/device/K170825
Methodology: https://510kreport.com/methodology